Literature DB >> 21036852

Demographic and clinical factors associated with persistent symptoms after West Nile virus infection.

Robert L Cook1, Xiaohui Xu, Eric J Yablonsky, Nikole Sakata, Jennifer H Tripp, Rachel Hess, Paolo Piazza, Charles R Rinaldo.   

Abstract

Prognosis varies among persons with West Nile virus (WNV) infection, but the most important factors associated with persistent symptoms are not clear. In this cross-sectional study, 265 persons with symptomatic WNV infection during 2006-2008 completed a survey a mean of 7.7 months after diagnosis. We determined the association of demographic and clinical characteristics to the most common symptoms. Of 214 persons infected ≥ 6 months, 53% reported one or more persistent symptoms, including fatigue, muscle aches, decreased activity, difficulty with memory, and difficulty concentrating. Persons with neuroinvasive disease, hypertension, or diabetes were significantly more likely to report persistent symptoms, whereas age, sex, and time since infection were not associated with persistent symptoms. In conclusion, persistent symptoms persisted in most persons for more than six months after symptomatic WNV infection. Improved strategies for prevention and treatment are needed.

Entities:  

Mesh:

Year:  2010        PMID: 21036852      PMCID: PMC2963984          DOI: 10.4269/ajtmh.2010.09-0717

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Outcome of West Nile fever in older adults.

Authors:  Yitshal N Berner; Ruth Lang; Michal Y Chowers
Journal:  J Am Geriatr Soc       Date:  2002-11       Impact factor: 5.562

2.  West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors.

Authors:  Tracy D Murphy; Joe Grandpre; Sandra L Novick; Scott A Seys; Richard W Harris; Karl Musgrave
Journal:  Vector Borne Zoonotic Dis       Date:  2005       Impact factor: 2.133

3.  Clinical description and follow-up investigation of human West Nile virus cases.

Authors:  Kristy Gottfried; Robbie Quinn; Tim Jones
Journal:  South Med J       Date:  2005-06       Impact factor: 0.954

4.  One-year sequelae in patients with West Nile Virus encephalitis and meningitis in Louisiana.

Authors:  Alan C Ou; Raoult C Ratard
Journal:  J La State Med Soc       Date:  2005 Jan-Feb

5.  Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey.

Authors:  F Mostashari; M L Bunning; P T Kitsutani; D A Singer; D Nash; M J Cooper; N Katz; K A Liljebjelke; B J Biggerstaff; A D Fine; M C Layton; S M Mullin; A J Johnson; D A Martin; E B Hayes; G L Campbell
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

6.  Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors.

Authors:  S L Orton; S L Stramer; R Y Dodd
Journal:  Transfusion       Date:  2006-02       Impact factor: 3.157

7.  Risk factors for encephalitis from West Nile Virus: a matched case-control study using hospitalized controls.

Authors:  K O Murray; E Koers; S Baraniuk; E Herrington; H Carter; M Sierra; C Kilborn; R Arafat
Journal:  Zoonoses Public Health       Date:  2009-08       Impact factor: 2.702

8.  Clinical characteristics and functional outcomes of West Nile Fever.

Authors:  John T Watson; Peter E Pertel; Roderick C Jones; Alicia M Siston; William S Paul; Constance C Austin; Susan I Gerber
Journal:  Ann Intern Med       Date:  2004-09-07       Impact factor: 25.391

9.  Neurologic manifestations and outcome of West Nile virus infection.

Authors:  James J Sejvar; Maryam B Haddad; Bruce C Tierney; Grant L Campbell; Anthony A Marfin; Jay A Van Gerpen; Aaron Fleischauer; A Arturo Leis; Dobrivoje S Stokic; Lyle R Petersen
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

10.  Long-term prognosis for clinical West Nile virus infection.

Authors:  Anne Labowitz Klee; Beth Maidin; Barbara Edwin; Iqbal Poshni; Farzad Mostashari; Annie Fine; Marcelle Layton; Denis Nash
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

View more
  27 in total

1.  West nile virus.

Authors:  Georg Pauli; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-07-04       Impact factor: 3.747

2.  A West Nile virus NS4B-P38G mutant strain induces cell intrinsic innate cytokine responses in human monocytic and macrophage cells.

Authors:  Guorui Xie; Huanle Luo; Bing Tian; Brian Mann; Xiaoyong Bao; Jere McBride; Robert Tesh; Alan D Barrett; Tian Wang
Journal:  Vaccine       Date:  2015-01-03       Impact factor: 3.641

Review 3.  Regulation of cell survival and death during Flavivirus infections.

Authors:  Sounak Ghosh Roy; Beata Sadigh; Emmanuel Datan; Richard A Lockshin; Zahra Zakeri
Journal:  World J Biol Chem       Date:  2014-05-26

Review 4.  Neurological approaches for investigating West Nile virus disease and its treatment in rodents.

Authors:  John D Morrey; Venkatraman Siddharthan; Hong Wang
Journal:  Antiviral Res       Date:  2013-09-19       Impact factor: 5.970

5.  TLR signaling controls lethal encephalitis in WNV-infected brain.

Authors:  Amir H Sabouri; Maria Cecilia Garibaldi Marcondes; Claudia Flynn; Michael Berger; Nengming Xiao; Howard S Fox; Nora E Sarvetnick
Journal:  Brain Res       Date:  2014-06-11       Impact factor: 3.252

6.  Treatment of spatial memory impairment in hamsters infected with West Nile virus using a humanized monoclonal antibody MGAWN1.

Authors:  Cynthia A Smeraski; Venkatraman Siddharthan; John D Morrey
Journal:  Antiviral Res       Date:  2011-04-30       Impact factor: 5.970

Review 7.  West Nile virus: review of the literature.

Authors:  Lyle R Petersen; Aaron C Brault; Roger S Nasci
Journal:  JAMA       Date:  2013-07-17       Impact factor: 56.272

8.  Initial and long-term costs of patients hospitalized with West Nile virus disease.

Authors:  J Erin Staples; Manjunath B Shankar; James J Sejvar; Martin I Meltzer; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2014-02-10       Impact factor: 2.345

9.  A hamster-derived West Nile virus strain is highly attenuated and induces a differential proinflammatory cytokine response in two murine cell lines.

Authors:  Vandana Saxena; Thomas Welte; Xiaoyong Bao; Guorui Xie; Jia Wang; Stephen Higgs; Robert B Tesh; Tian Wang
Journal:  Virus Res       Date:  2012-05-10       Impact factor: 3.303

10.  Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection.

Authors:  Huanle Luo; Evandro R Winkelmann; Shuang Zhu; Wenjuan Ru; Elizabeth Mays; Jesus A Silvas; Lauren L Vollmer; Junling Gao; Bi-Hung Peng; Nathen E Bopp; Courtney Cromer; Chao Shan; Guorui Xie; Guangyu Li; Robert Tesh; Vsevolod L Popov; Pei-Yong Shi; Shao-Cong Sun; Ping Wu; Robyn S Klein; Shao-Jun Tang; Wenbo Zhang; Patricia V Aguilar; Tian Wang
Journal:  J Clin Invest       Date:  2018-09-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.